News of the index components OMX NORDIC 40

Index

OMXN40

SE0001809476

Market Closed - Nasdaq Stockholm 09:05:07 21/06/2024 pm IST			5-day change	1st Jan Change
2,903 ^PTS	-0.52%		+0.21%	+14.43%

05/06	Nordic Shares Moved Upward Wednesday; Crayon Group Topped Leaders	DJ
31/05	Nordic Shares Moved Upward Friday; NEL Topped Leaders	DJ

News of the index components

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Transcript : Genmab A/S - Special Call GMAB	03/06
Investigational Tisotumab Vedotin Phase 2 Data Demonstrates Encouraging Antitumor Activity in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) GMAB	03/06	BU
Transactions in Connection with Share Buy-back Program GMAB	03/06	GL
Investigational Tisotumab Vedotin Phase 2 Data Demonstrates Encouraging Antitumor Activity in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) GMAB	03/06	GL
Genmab A/S Announces Data from the Phase 2 Innovatv 207 Trial, Investigating Tisotumab Vedotin GMAB	03/06	CI
Genmab A S and BioNTech SE Announces Initial Data from the Ongoing Phase 2 Trial GMAB	03/06	CI
Carlsberg A/S : Brooklyn Brewery and Spike Lee collaborate to create global campaign CARL B	03/06	PU
Nokia Enters Partnership for Transportation, Logistics Technology Research in India NOKIA	03/06	MT
Nokia Bags Infrastructure Upgrade Contract from Telehouse America NOKIA	03/06	MT
JPMorgan European G&I raises dividend after outperforming benchmark NOVO B	03/06	AN
Carlsberg A/S share buy-back programme CARL B	03/06	AQ
Ericsson Concludes Anti-corruption Compliance Monitoring With US Government ERIC B	03/06	MT
AP Moller Maersk : Tax information MAERSK B	03/06	PU
Ericsson Reports Conclusion of DOJ Monitorship ERIC B	03/06	MT
Ericsson: end of anti-corruption surveillance in the USA ERIC B	03/06	CF
Carlsberg A/S : appoints two new members of Executive Committee CARL B	03/06	PU
Nokia and Gati Shakti Vishwavidyalaya sign MoU for research collaboration on transportation and logistics NOKIA	03/06	AQ
Danske Bank share buy-back programme: Transactions in week 22 DANSKE	03/06	GL
Nokia and Gati Shakti Vishwavidyalaya Sign MOU for Research Collaboration on Transportation and Logistics NOKIA	03/06	CI
Ericsson says U.S. anti-corruption compliance monitoring has ended ERIC B	03/06	RE
Nokia selected by Telehouse America to upgrade NYIIX peering exchange infrastructure in the US NOKIA	03/06	AQ
Telehouse America Selects Nokia to Upgrade NYIIX Peering Exchange Infrastructure in the US NOKIA	03/06	CI
Ericsson Concludes U.S. Plea Deal Following Bribery Allegations ERIC B	03/06	DJ
Fortum Oyj : Battery Recycling Oy and Marubeni Corporation sign Memorandum of Understanding to address the demand for recycled raw materials FORTUM	03/06	PU
Ericsson announces conclusion of Monitorship ERIC B	03/06	AQ
Genmab Announces Initial Data from Phase 2 Cancer Treatment Trial GMAB	03/06	MT
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma GMAB	03/06	AQ
Genmab A/S Announces New Efficacy and Safety Data from Two Ongoing Phase 1/2 Clinical Trials Evaluating Epcoritamab, A T-Cell Engaging Bispecific Antibody Administered Subcutaneously, in Adult Patients with Certain Types of Follicular Lymphoma GMAB	03/06	CI
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma GMAB	03/06	GL
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma GMAB	03/06	BU
ESSITY : EPS cut (2023: -9.6%, 2024: -1.3%) ESSITY B	01/06
Genmab A/S : Investigational Acasunlimab (DuoBody® PD L1x4 1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non small Cell Lung Cancer (mNSCLC) GMAB	01/06	PU
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) GMAB	01/06	BU
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) GMAB	01/06	GL
Nokia Corporation: Repurchase of own shares on 31.05.2024 NOKIA	01/06	GL
Pioneering sustainable shipping with Alfa Laval at Posidonia ALFA	31/05	AQ
H&M: new concept store opens in Seoul HM B	31/05	CF
Trading by management and close relations of management NSIS B	31/05	GL
Stora Enso Oyj : Marimekko and Stora Enso collaborate to create new, dynamic and renewable gift packaging STERV	31/05	PU
Danske Bank A/S : Active Ownership Instruction DANSKE	31/05	PU